UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 362

Sortiert nach

Weight gain and integrase inhibitors

Current opinion in infectious diseases, 2020-02, Vol.33 (1), p.10

2020

Volltextzugriff (PDF)

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1379-1389

2020

Volltextzugriff (PDF)

Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers

Clinical infectious diseases, 2010-10, Vol.51 (8), p.937-946

2010

Volltextzugriff (PDF)

Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection

PloS one, 2018-07, Vol.13 (7), p.e0200285-e0200285

2018

Volltextzugriff (PDF)

Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection

AIDS (London), 2016-09, Vol.30 (14), p.2195-2203

2016

Volltextzugriff (PDF)

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

Clinical infectious diseases, 2020-12, Vol.71 (9), p.e471-e477

2020

Volltextzugriff (PDF)

HIV and race are independently associated with endothelial dysfunction

AIDS (London), 2023-02, Vol.37 (2), p.271-277

2023

Volltextzugriff (PDF)

Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy

Diabetes care, 2010-10, Vol.33 (10), p.2244-2249

2010

Volltextzugriff (PDF)

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States

Advances in therapy, 2021-09, Vol.38 (9), p.4961-4974

2021

Volltextzugriff (PDF)

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

The Journal of infectious diseases, 2011-06, Vol.203 (12), p.1791-1801

2011

Volltextzugriff (PDF)

Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control

Medicine (Baltimore), 2022-10, Vol.101 (42), p.e31125-e31125

2022

Volltextzugriff (PDF)

Obesity and Fat Metabolism in Human Immunodeficiency Virus-Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications

The Journal of infectious diseases, 2019-07, Vol.220 (3), p.420-431

2019

Volltextzugriff (PDF)

Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study

Frontiers in immunology, 2024, Vol.15, p.1297195-1297195

2024

Volltextzugriff (PDF)

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy

Clinical infectious diseases, 2009-10, Vol.49 (7), p.1119-1127

2009

Volltextzugriff (PDF)

Gut permeability is associated with lower insulin sensitivity in youth with perinatally acquired HIV

AIDS (London), 2024-07, Vol.38 (8), p.1163

2024

Volltextzugriff (PDF)

Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells

The Journal of infectious diseases, 2011-10, Vol.204 (8), p.1217-1226

2011

Volltextzugriff (PDF)

Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2014-04, Vol.209 (8), p.1156-1164

2014

Volltextzugriff (PDF)

Zinc Deficiency And sTNF-RII Are Associated With Worse COVID-19 Outcomes

The Journal of nutrition, 2024-05, Vol.154 (5), p.1588-1595

2024

Volltextzugriff (PDF)

Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2015-04, Vol.68 (4), p.396

2015

Volltextzugriff (PDF)

Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV

AIDS (London), 2024-02, Vol.38 (2), p.177

2024

Volltextzugriff (PDF)

Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials

Clinical infectious diseases, 2021-10, Vol.73 (8), p.1440-1451

2021

Volltextzugriff (PDF)

HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy

Journal of women's health (Larchmont, N.Y. 2002), 2018-09, Vol.27 (9), p.1162

2018

Volltextzugriff (PDF)

Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s

Clinical infectious diseases, 2016-04, Vol.62 (7), p.853-862

2016

Volltextzugriff (PDF)

New-onset autoimmune disease after COVID-19

Frontiers in immunology, 2024-02, Vol.15, p.1337406-1337406

2024

Volltextzugriff (PDF)

Bisphosphonates in Perinatally Infected Children and Adolescents With Human Immunodeficiency Virus: Targeting Puberty

Clinical infectious diseases, 2020-08, Vol.71 (5), p.1289-1291

2020

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

Englisch
(362)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Weight gain and integrase inhibitors

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers

Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection

Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

HIV and race are independently associated with endothelial dysfunction

Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control

Obesity and Fat Metabolism in Human Immunodeficiency Virus-Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications

Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy

Gut permeability is associated with lower insulin sensitivity in youth with perinatally acquired HIV

Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells

Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy

Zinc Deficiency And sTNF-RII Are Associated With Worse COVID-19 Outcomes

Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy

Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV

Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials

HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy

Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s

New-onset autoimmune disease after COVID-19

Bisphosphonates in Perinatally Infected Children and Adolescents With Human Immunodeficiency Virus: Targeting Puberty

Suchergebnisse filtern